goa conference 2023
6-8 sept 2023
LISBOA BALL ROOM, Radisson Blu Resort, Goa
6 sept – day 1
8:00-8:20
am
Registration
Outside LISBOA Ball Room
8:20-8:35
am
Welcome & Introduction
Sudha Srinivasan, National Institutes of Health, USA, Jyoti Logani, Department of Biotechnology, India, Jerry Ellner, RePORT International
8:35-8:50
am
Overview of RePORT India & RePORT International
Sonali Sarkar, RePORT India & Jerry Ellner, RePORT International
8:50-9:00
am
Role of RePORT International in NIAID TB Programs
Peter Kim/Fatima Jones, National Institutes of Health, USA
9:00-9:30
am
Keynote Address
Rajesh Gokhale, Secretary for Department of Biotechnology & Department of Science & Technology, Government of India
Basic Research – MTb Survival
Dhiraj Kumar & Padmini Salgame
9:30-9:55
am
Delineating Survival Strategies Employed by Mycobacterium Tuberculosis
Vinay Nandicoori, CSIR-Centre for Cellular & Molecular Biology
9:55-10:20
am
Targeting Host-Pathogen Heterogenous Interactions to Counteract Drug Tolerance in M. Tuberculosis
Amit Singh, Indian Institute of Science (IISc) Bangalore
10:20-10:45
am
Mycobacterium Tuberculosis Biofilms: Their Role in Drug Tolerance & Immune Evasion
Ashwani Kumar, CSIR – Institute of Microbial Technology
10:45-11:00 AM
Coffee & Tea Break
Vaccines
Amit Singh & Mark Hatherill
11:00-11:25
am
Vaccines to Prevent TB Infection & Immunology
Mark Hatherill & Tom Scriba, RePORT South Africa
11:25-11:50
am
Vaccines: VPM
Umesh Shaligram, Serum Institute
11:50-12:15
am-pm
VPM1002 Overview & Immunology
Vidya Mave & Padmini Salgame, RePORT India
12:15-12:40
pm
VPM1002 ICMR Trial in Close Contacts
Manjula Singh, ICMR
12:40-1:00
pm
IeDEA Tuberculosis Sentinel Research Network (TB-SRN)
Jeremy Ross, IeDEA
1:00 – 1:20
pm
Innovation in AI Based TB Case Finding
Shibu Vijayan, Qure.ai
1:20 PM
Group Photo & Lunch
operational agenda
Break Out Session, Members Only
2:30-4:00
pm
Bylaws Committee
Stephany Duda
4:00-4:15 PM
Coffee & Tea Break
4:15-5:45
pm
Scientific Review Committee
Tim Sterling & Mark Hatherill
6:30 PM
Networking Dinner
7 sept – day 2
8:00-8:15
am
Introduction & Overview of TB Survivors Program in India
Amita Gupta, RePORT India & Chapal Mehra, TB Survivors
8:15-8:30
am
A TB Survivor’s Journey
Dipti Chavan, TB Survivors Program
8:30-8:50
am
Lung Health Study Updates
Hardy Kornfeld, UMass Chan Medical School – Worcester
Early TB
Vijaya Valluri & Bruno Andrade
8:50-9:15
am
Subclinical TB: What we have Learned from a Community-Based Study in KwaZulu-Natal
Emily Wong, AHRI
9:15-9:40
am
PET-CT & Biomarkers in Subclinical TB
Anna Coussens, Walter and Eliza Hall Institute (WEHI)
9:40-10:05
am
Modeling Sub Clinical TB
Tess Rykman, Johns Hopkins University
10:05-10:20
am
Incidence & Determinants of Subclinical & Clinical Recurrence of Tuberculosis among Cured Pulmonary Tuberculosis Patients in India
Mandar Paradkar, RePORT India (Junior Investigator)
10:20-10:35
am-pm
A Comprehensive Multiomic Analysis of the Tuberculosis & Diabetes Interaction
Mariana Araújo Pereira, RePORT Brazil (Junior Investigator)
10:35-10:50 AM
Coffee & Tea Break
Sub Clinical TB
DJ Christopher & Tim Sterling
10:50-11:05
am
Gene Signatures for Monitoring Treatment
Response & Predicting Cure Among TB
Patients in Brazil
Simon C Mendelsohn, RePORT South Africa (Junior Investigator)
11:05-11:20
am
Impact of Premorbid Nutritional Status on
Tuberculosis Severity in India: A Multicenter Prospective Cohort Analysis
Komal Jain (on behalf of Xinyi Du), RePORT India (Junior Investigator)
11:20-11:35
am
The Sound of Silent RNA: The Role of Long Non-Coding RNA on Tuberculosis in 4 Different Populations
Artur Trancoso Lopo de Queiroz, RePORT Brazil (Junior Investigator)
11:35-11:50
am
Population Pharmacokinetics of Moxifloxacin in Indian Patients with Multidrug-Resistance Tuberculosis
Prerna Arora, RePORT India (Junior Investigator)
11:50-12:15
am-pm
IGRA Conversion/Reversion
Sheetal Verma, Rutgers University
12:15-12:40
pm
Immune Biomarkers for TB Progression in a Cohort Study of Household Contact
Prudhula Kamakshi, Bhagwan Mahavir Medical Research Centre
12:40-1:05
pm
Urine & Serum Biomarker Analyses in Cohort B samples from RePORT South Africa
Karen Dobos & John Belisle, Colorado State University
1:05-1:25
pm
Towards a Systems Pharmacology Mathematical Model for EPTB
Chetan Gadgil, National Chemical Laboratory, Pune
1:25-1:40
pm
Introduction to SMART4TB
Bob Bollinger, Johns Hopkins University
1:40-2:00
pm
Closing of Scientific Sessions
DJ Christopher & Mark Hatherill
2:00 PM
Poster Session & Lunch Break
operational agenda
Break Out Session, Members Only
2:45 – 4:15
pm
Common Protocol
Stephany Duda & Ann Tufariello
4:15-4:30 PM
Coffee & Tea Break
4:30-6:00
pm
Capacity Strengthening
Bob Bollinger & Valeria Rolla
FREE Evening
8 sept – day 3
Scientific Country Updates
Stephany Duda & Marissa Alejandria
8:00-8:20
am
RePORT Brazil
Country Representative
8:20-8:40
am
RePORT India
Country Representative
8:40-9:00
am
RePORT Indonesia
Country Representative
9:00-9:15
am
RePORT Korea
Country Representative
9:15-9:35
am
RePORT Philippines
Country Representative
9:35-9:55
am
RePORT South Africa
Country Representative
9:55-10:10
am
RePORT Uganda
Country Representative
10:10-10:30 AM
Coffee & Tea Break
Working Group & Protocol
Action Items & Approvals
10:35-10:55
am
Biomarker Protocol
Padmini Salgame
10:55-11:15
am
Data Harmonization
Stephany Duda & Sri Ram Pentakota
11:15-11:35
am
Scientific Review Committee
Tim Sterling & Mark Hatherill
11:35-12:00
am-pm
Capacity Strengthening
Bob Bollinger
12:00-12:30
pm
Bylaws Committee
Stephany Duda
12:30-1:00
pm
Common Protocol
Stephany Duda & Ann Tufariello
1:30 PM
Closing & Lunch, Meeting Co-Chairs
What's new
CRDF Global
CRDF GlobaLLongstanding Partners in International ResearchCRDF Global has been part of RePORT International’s research management processes for many years. This month, we wished to learn more about its history and the people who make it a successful and efficient. We...
Mutually Beneficial Collaboration
Mutually Beneficial CollabThe NIH, Infectious Diseases, and RePORT International: A Long-standing, Mutually Beneficial CollaborationThe National Institute of Allergy and Infectious Diseases (NIAID) under the US-based National Institutes of Health (NIH) had a long...
Applying Science to TB
Applying Science to TB Prevention and CareRePORT PhilippinesOrigin StoryThe Philippines remains to be among the top five high burden countries for TB with a continued increase in cases and deaths from 2015 to 2022. RePORT Philippines is a collaborative effort that was...